XML 15 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jan. 31, 2019
Apr. 30, 2018
Current Assets:    
Cash and cash equivalents $ 10,771 $ 9,716
Restricted cash 606 1,242
Receivables, less allowance; $361; $384, on each respective date 27,929 32,660
Inventories 16,672 18,549
Prepaid expenses and other current assets 3,778 2,224
Total Current Assets 59,756 64,391
Property, plant and equipment, at cost 56,791 54,648
Accumulated depreciation (41,589) (39,987)
Net Property, Plant and Equipment 15,202 14,661
Deferred income taxes 1,676 1,869
Other assets 2,928 4,162
Total Other Assets 4,604 6,031
Total Assets 79,562 85,083
Current Liabilities:    
Short-term borrowings and interest rate swaps 5,118 3,885
Current portion of long-term debt and lease obligations 1,184 1,167
Accounts payable 11,106 14,754
Employee compensation and amounts withheld 1,954 3,810
Deferred revenue 1,450 1,884
Other accrued expenses 2,894 2,116
Total Current Liabilities 23,706 27,616
Long-term debt and lease obligations 526 1,264
Accrued pension and deferred compensation costs 5,480 7,465
Income taxes payable 339 546
Total Liabilities 30,051 36,891
Commitments and Contingencies
Stockholders’ Equity:    
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,747 shares; 2,736 shares; – Outstanding – 2,744 shares; 2,733 shares, on each respective date 6,869 6,841
Additional paid-in-capital 3,342 3,006
Retained earnings 45,345 43,836
Accumulated other comprehensive loss (6,513) (5,900)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders’ Equity 48,990 47,730
Noncontrolling interest 521 462
Total Stockholders’ Equity 49,511 48,192
Total Liabilities and Stockholders’ Equity $ 79,562 $ 85,083